Imbalance in the blood antioxidant system in growth hormone-deficient children before and after 1 year of recombinant growth hormone therapy

The aim of our study was to examine the effects of 12-month therapy with recombinant growth hormone (rGH) on the blood antioxidant system in children with growth hormone deficiency (GHD). Total antioxidant capacity (TAC) of plasma was measured by FRAP (ferric reducing antioxidant power or ferric red...

Descripción completa

Detalles Bibliográficos
Autores principales: Pankratova, Maria S., Baizhumanov, Adil A., Yusipovich, Alexander I., Faassen, Maria, Shiryaeva, Tatyana Yu., Peterkova, Valentina A., Kovalenko, Svetlana S., Kazakova, Tatiana A., Maksimov, Georgy V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2015
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485705/
https://www.ncbi.nlm.nih.gov/pubmed/26137433
http://dx.doi.org/10.7717/peerj.1055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485705/
https://www.ncbi.nlm.nih.gov/pubmed/26137433
http://dx.doi.org/10.7717/peerj.1055

Ejemplares similares